MARKET

AKUS

Akouos, Inc.
AKUS
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-3.4524
-
2.714
491,015,144.19
Around $375 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying
Benzinga · 12/02/2022 11:37
BRIEF-Lilly Completes Acquisition Of Akouos Expanding Efforts To Help People With Genetic Diseases
Reuters · 12/01/2022 13:53
BRIEF-Lilly And Akouos Announce Expiration Of Akouos Tender Offer
Reuters · 11/30/2022 12:38
Akouos GAAP EPS of -$0.54 beats by $0.11
Seekingalpha · 11/14/2022 14:19
BRIEF-Akouos Inc Reports Q3 Loss Per Share Of $0.54
Reuters · 11/14/2022 13:38
Akouos Q3 EPS $(0.54) Up From $(0.67) YoY
Benzinga · 11/14/2022 12:28
The Zacks Analyst Blog Highlights J&J, Roche, Eli Lilly and AbbVie
J&J, Roche, Eli Lilly and AbbVie are part of The Zacks top Analyst Blog.
Zacks · 10/24/2022 13:35
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
Upgrades
Benzinga · 10/19/2022 14:02
More

Webull offers kinds of Akouos, Inc. stock information, including NASDAQ:AKUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKUS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AKUS stock methods without spending real money on the virtual paper trading platform.